Literature DB >> 23046917

Health-related quality of life after spontaneous subarachnoid hemorrhage measured in a recent patient population.

Martin Tjahjadi1, Christian Heinen, Ralph König, Eckhard Rickels, Christian Rainer Wirtz, Dieter Woischneck, Thomas Kapapa.   

Abstract

OBJECTIVE: This study sought to determine the impact of spontaneous subarachnoid hemorrhage (SAH) on health-related quality of life (HRQOL).
METHODS: Data were taken retrospectively from 601 patients (219 male, 382 female) treated between 1998 and 2008. Questionnaires concerning HRQOL were circulated prospectively, and the responses from 253 patients (81 male, 172 female) were analyzed. The questionnaires comprised the standardized Short-Form 36 (SF-36) and Short-Form 12 (SF-12) Health Surveys, a number of nonstandardized questions, and visual analogue scales. Statistical analysis of the results was exploratory, using unifactorial ANOVA (Scheffe), multivariate analyses of variance.
RESULTS: The HRQOL is reduced considerably by SAH and remains so for a period of 10 years. Physical and emotional domains are primarily affected, but also cognitive functions, including memory and concentration in particular. Similarly, certain roles are affected that prove difficult to rehabilitate after acute care and cause serious debility in the long term. The Hunt and Hess Scale, Glasgow Outcome Scale, and seizures were found to have the greatest impact on HRQOL.
CONCLUSIONS: Documentation of HRQOL after 6 to 12 months is useful because patients are often found to have a diminished HRQOL in the absence of a clear physical impairment. Because psychological, emotional, cognitive, and social functioning influence HRQOL in the long term, efforts at rehabilitation should focus in particular on improving such factors. Documentation of HRQOL is a useful, additive tool for consolidating and evaluating the outcome, and a treatment end point after SAH, respectively.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23046917     DOI: 10.1016/j.wneu.2012.10.009

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group.

Authors:  Martin N Stienen; Johanna M Visser-Meily; Tom A Schweizer; Daniel Hänggi; R Loch Macdonald; Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

Review 2.  Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies.

Authors:  Marcey L Osgood
Journal:  Curr Neurol Neurosci Rep       Date:  2021-07-26       Impact factor: 5.081

3.  The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study.

Authors:  Sumithra Giritharan; Joanna Cox; Calvin J Heal; David Hughes; Kanna Gnanalingham; Tara Kearney
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

4.  Delayed Leukoencephalopathy and Foreign Body Reaction After Endovascular Treatment in Patients With Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage-A Systematic Review of the Literature.

Authors:  Sami Ridwan; Jörg Andreas Kandyba; Anita Schug; Elina Malsagov; Nikolaos Karageorgos; Franz-Josef Hans
Journal:  Front Surg       Date:  2021-12-23

5.  Adverse Events and Complications in Continuous Intra-arterial Nimodipine Infusion Therapy After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Thomas Kapapa; Ralph König; Benjamin Mayer; Michael Braun; Bernd Schmitz; Silwia Müller; Julia Schick; Christian Rainer Wirtz; Andrej Pala
Journal:  Front Neurol       Date:  2022-02-18       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.